The future for antibiotics: Bacterial membrane disintegrators

Drugs of the Future

Volumn 28, Issue 9, 2003, Pages 911-923

  Lockwood, Nathan A ^a,b   Mayo, Kevin H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; AMOXICILLIN; AMPICILLIN; AMPICILLIN DERIVATIVE; AMPICILLIN PLUS CLAVULANATE; ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL ENZYME; CARBAPENEM; CECROPIN; CEFOTAXIME; CEPHALOSPORIN; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GRAMICIDIN S; MAGAININ DERIVATIVE; METICILLIN; PENICILLIN G; POLYMYXIN B; POLYMYXIN M; PROTEGRIN; QUINOLONE; SQUALAMINE; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIFUNGAL ACTIVITY; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL MUTATION; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ESCHERICHIA COLI; HUMAN; NONHUMAN; REVIEW; STREPTOCOCCUS PNEUMONIA; STRUCTURE ANALYSIS;

EID: 0346993728     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2003.028.09.857379     Document Type: Review

References (125)

1. Cohen, M.L. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science 1992, 257: 1050-5.
2. Virk, A.M.D., Steckelberg, J.M.M.D. Clinical aspects of antimicrobial resistance. Mayo Clin Proc 2000, 75: 200-14.
3. Stratton, C.W. Dead bugs don't mutate: Susceptibility issues in the emergence of bacterial resistance. Emerg Infect Dis 2003, 9: 10-6.
4. Neu, H.C. The crisis in antibiotic resistance. Science 1992, 257: 1064-73.
5. Kunin, C.M. Resistance to antimicrobial drugs - a worldwide calamity. Ann Intern Med 1993, 118: 557-61.
6. Levy, S.B. Multidrug resistance - a sign of the times. New Engl J Med 1998, 338: 1376-8.
7. Garcia-Olmedo, F., Molina, A., Alamillo, J.M., Rodriguez-Palenzuela, P. Plant defense peptides. Biopolymers 1998, 47: 479-91.
8. Otvos, L. Antibacterial peptides isolated from insects. J Pept Sci 2000, 6: 497-511.
9. Bulet, P., Hetru, C., Dimarcq, J.L., Hoffmann, D. Antimicrobial peptides in insects: Structure and function. Dev Comp Immunol 1999, 23: 329-44.
10. Simmaco, M., Mignogna, G., Barra, D. Antimicrobial peptides from amphibian skin: What do they tell us? Biopolymers 1998, 47: 435-50.
11. Ganz, T. Antimicrobial proteins and peptides in host defense. Semin Respir Infect 2001, 16: 4-10.
12. Ganz, T., Lehrer, R.I. Antimicrobial peptides of leukocytes. Curr Opin Hematol 1997, 4: 53-8.
13. Levy, O. Antimicrobial proteins and peptides of blood: Templates for novel antimicrobial agents. Blood 2000, 96: 2664-72.
14. Tossi, A. Antimicrobial sequences database. Department of Biochemistry, Biophysics, and Macromolecular Chemistry, University of Trieste, Trieste, Italy 2003, http://www.bbcm.units.it/
15. Whitmore, L., Chugh, J., Snook, C.F., Wallace, B.A. Peptaibol database. School of Crystallography, Birkbeck College, University of London, London, U.K. 2003, http://www.cryst.bbk.ac.uk/peptaibol/home.shtml
16. Giangaspero, A., Sandri, L., Tossi, A. Amphipathic alpha helical antimicrobial peptides. Eur J Biochem 2001, 268: 5589-600.
17. Matsuzaki, K., Sugishita, K., Harada, M., Fujii, N., Miyajima, K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta 1997, 1327: 119-30.
18. Andreu, D., Merrifield, R.B., Steiner, H., Boman, H.G. N-terminal analogues of cecropin A: Synthesis, antibacterial activity, and conformational properties. Biochemistry 1985, 24: 1683-8.
19. Bechinger, B., Zasloff, M., Opella, S.J. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci 1993, 2: 2077-84.
20. Habermann, E., Jentsch, J. Sequence analysis of melittin from tryptic and peptic degradation products. Hoppe Seylers Z Physiol Chem 1967, 348: 37-50.
21. Zasloff, M. Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1987, 84: 5449-53.
22. Toniolo, C., Crisma, M., Formaggio, F., Peggion, C., Epand, R.F., Epand, R.M. Lipopeptaibols, a novel family of membrane active, antimicrobial peptides. Cell Mol Life Sci 2001, 58: 1179-88.
23. Benedetti, E., Bavoso, A., Di Blasio, B. et al. Peptaibol antibiotics: A study on the helical structure of the 2-9 sequence of emerimicins III and IV. Proc Natl Acad Sci USA 1982, 79: 7951-4.
24. Brückner, H., Graf, H. Paracelsin, a peptide antibiotic containing α-aminoisobutyric acid, isolated from Trichoderma reesei Simmons, part A. Experientia 1983, 39: 528-30.
25. Auvin-Guette, C., Rebuffat, S., Prigent, Y., Bodo, B. Trichogin AG IV, an 11-residue lipopeptaibol from Trichoderma longibrachiatum. J Am Chem Soc 1992, 114: 2170-4.
26. Zimmermann, G.R., Legault, P., Selsted, M.E., Pardi, A. Solution structure of bovine neutrophil β-defensin-12: The peptide fold of the β-defensins is identical to that of the classical defensins. Biochemistry 1995, 34: 13663-71.
27. Fellermann, K., Stange, E.F. Defensins - innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 2001, 13: 771-6.
28. Kokryakov, V.N., Harwig, S.S., Panyutich, E.A. et al. Protegrins: Leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 1993, 327: 231-6.
29. Sokolov, Y., Mirzabekov, T., Martin, D.W., Lehrer, R.I., Kagan, B.L. Membrane channel formation by antimicrobial protegrins. Biochim Biophys Acta 1999, 1420: 23-9.
30. Bellamy, W., Takase, M., Wakabayashi, H., Kawase, K., Tomita, M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 1992, 73: 472-9.
31. Tsai, H., Bobek, L.A. Human salivary histatins: Promising anti-fungal therapeutic agents. Crit Rev Oral Biol Med 1998, 9: 480-97.
32. Agerberth, B., Lee, J.Y., Bergman, T. et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 1991, 202: 849-54.
33. Selsted, M.E., Novotny, M.J., Morris, W.L., Tang, Y.Q., Smith, W., Cullor, J.S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem 1992, 267: 4292-5.
34. Staubitz, P., Peschel, A., Nieuwenhuizen, W.F. et al. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J Pept Sci 2001, 7: 552-64.
35. Lawyer, C., Pai, S., Watabe, M. et al. Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Lett 1996, 390: 95-8.
36. HsuChen, C.C., Feingold, D.S. The mechanism of polymyxin B action and selectivity toward biologic membranes. Biochemistry 1973, 12: 2105-11.
37. Martin, N.I., Hu, H., Moake, M.M. et al. Isolation, structural characterization, and properties of mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M. J Biol Chem 2003, 278: 13124-32.
38. Kondejewski, L.H., Farmer, S.W., Wishart, D.S., Hancock, R.E., Hodges, R.S. Gramicidin S is active against both Gram-positive and Gram-negative bacteria. Int J Pept Protein Res 1996, 47: 460-6.
39. Kondejewski, L.H., Farmer, S.W., Wishart, D.S., Kay, C.M., Hancock, R.E., Hodges, R.S. Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. J Biol Chem 1996, 271: 25261-8.
40. Prenner, E.J., Lewis, R.N., McElhaney, R.N. The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes. Biochim Biophys Acta 1999, 1462: 201-21.
41. Moore, K.S., Wehrli, S., Roder, H. et al. Squalamine: An aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 1993, 90: 1354-8.
42. Selinsky, B.S., Zhou, Z., Fojtik, K.G., Jones, S.R., Dollahon, N.R., Shinnar, A.E. The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles. Biochim Biophys Acta 1998, 1370: 218-34.
43. Selinsky, B.S., Smith, R., Frangiosi, A., Vonbaur, B., Pedersen, L. Squalamine is not a proton ionophore. Biochim Biophys Acta 2000, 1464: 135-41.
44. Wu, M., Maier, E., Benz, R., Hancock, R.E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 1999, 38: 7235-42.
45. White, S.H., Wimley, W.C., Selsted, M.E. Structure, function, and membrane integration of defensins. Curr Opin Struct Biol 1995, 5: 521-7.
46. Matsuzaki, K., Sugishita, K., Fujii, N., Miyajima, K. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 1995, 34: 3423-9.
47. Prenner, E.J., Lewis, R.N., Kondejewski, L.H., Hodges, R.S., McElhaney, R.N. Differential scanning calorimetric study of the effect of the antimicrobial peptide gramicidin S on the thermotropic phase behavior of phosphatidylcholine, phosphatidylethanolamine and phosphatidylglycerol lipid bilayer membranes. Biochim Biophys Acta 1999, 1417: 211-23.
48. Oren, Z., Shai, Y. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 1998, 47: 451-63.
49. Epand, R.M., Shai, Y., Segrest, J.P., Anantharamaiah, G.M. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers 1995, 37: 319-38.
50. Tytler, E.M., Segrest, J.P., Epand, R.M. et al. Reciprocal effects of apolipoprotein and lytic peptide analogs on membranes. Cross-sectional molecular shapes of amphipathic α helixes control membrane stability. J Biol Chem 1993, 268: 22112-8.
51. Ehrenstein, G., Lecar, H. Electrically gated ionic channels in lipid bilayers. Q Rev Biophys 1977, 10: 1-34.
52. Sansom, M.S. The biophysics of peptide models of ion channels. Prog Biophys Mol Biol 1991, 55: 139-235.
53. Bechinger, B. Structure and functions of channel-forming peptides: Magainins, cecropins, melittin and alamethicin. J Membr Biol 1997, 156: 197-211.
54. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999, 1462: 55-70.
55. Gazit, E., Boman, A., Boman, H.G., Shai, Y. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry 1995, 34: 11479-88.
56. Matsuzaki, K., Murase, O., Tokuda, H., Funakoshi, S., Fujii, N., Miyajima, K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry 1994, 33: 3342-9.
57. Ludtke, S.J., He, K., Heller, W.T., Harroun, T.A., Yang, L., Huang, H.W. Membrane pores induced by magainin. Biochemistry 1996, 35: 13723-8.
58. Peschel, A. How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002, 10: 179-86.
59. Guo, L., Lim, K.B., Poduje, C.M. et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998, 95: 189-98.
60. Peschel, A., Jack, R.W., Otto, M. et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 2001, 193: 1067-76.
61. Ernst, R.K., Yi, E.C., Guo, L. et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286: 1561-5.
62. Guina, T., Yi, E.C., Wang, H., Hackett, M., Miller, S.I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 2000, 182: 4077-86.
63. Shafer, W.M., Qu, X., Waring, A.J., Lehrer, R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci USA 1998, 95: 1829-33.
64. Wade, D., Englund, J. Synthetic antibiotic peptides database. J. Haartman Institute and the National Library of Health Sciences, Helsinki University, Helsinki, Finland 2003, http://oma.terkko.helsinki.fi:8080/SAPD/
65. Sitaram, N., Subbalakshmi, C., Nagaraj, R. Structural and charge requirements for antimicrobial and hemolytic activity in the peptide PKLLETFLSKWIG, corresponding to the hydrophobic region of the antimicrobial protein bovine seminalplasmin. Int J Pept Protein Res 1995, 46: 166-73.
66. Saberwal, G., Nagaraj, R. A synthetic peptide corresponding to the hydrophobic amino terminal region of pardaxin can perturb model membranes of phosphatidyl choline and serine. Biochim Biophys Acta 1989, 984: 360-4.
67. Tossi, A., Tarantino, C., Romeo, D. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur J Biochem 1997, 250: 549-58.
68. Blondelle, S.E., Perez-Paya, E., Houghten, R.A. Synthetic combinatorial libraries: Novel discovery strategy for identification of antimicrobial agents. Antimicrob Agents Chemother 1996, 40: 1067-71.
69. Dathe, M., Wieprecht, T. Structural features of helical antimicrobial peptides: Their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1999, 1462: 71-87.
70. Beven, L., Castano, S., Dufourcq, J., Wieslander, A., Wroblewski, H. The antibiotic activity of cationic linear amphipathic peptides: Lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. Eur J Biochem 2003, 270: 2207-17.
71. Hancock, R.E. Peptide antibiotics. Lancet 1997, 349: 418-22.
72. Hancock, R.E., Falla, T., Brown, M. Cationic bactericidal peptides. Adv Microb Physiol 1995, 37: 135-75.
73. Wieprecht, T., Dathe, M., Epand, R.M. et al. Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry 1997, 36: 12869-80.
74. Wieprecht, T., Dathe, M., Beyermann, M. et al. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry 1997, 36: 6124-32.
75. Wieprecht, T., Dathe, M., Krause, E. et al. Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett 1997, 417: 135-40.
76. Dathe, M., Wieprecht, T., Nikolenko, H. et al. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett 1997, 403: 208-12.
77. Kondejewski, L.H., Jelokhani-Niaraki, M., Farmer, S.W. et al. Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J Biol Chem 1999, 274: 13181-92.
78. Mayo, K.H., Ilyina, E., Park, H. A recipe for designing water-soluble, β-sheet-forming peptides. Protein Sci 1996, 5: 1301-15.
79. Mayo, K.H., Haseman, J., Ilyina, E., Gray, B. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities. Biochim Biophys Acta 1998, 1425: 81-92.
80. Little, R.G., Kelner, D.N., Lim, E., Burke, D.J., Conlon, P.J. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J Biol Chem 1994, 269: 1865-72.
81. Gray, B.H., Haseman, J.R., Mayo, K.H. B/PI-derived synthetic peptides: Synergistic effects in tethered bactericidal and endotoxin neutralizing peptides. Biochim Biophys Acta 1995, 1244: 185-90.
82. Beamer, L.J., Carroll, S.F., Eisenberg, D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 1997, 276: 1861-4.
83. Mayo, K.H., Haseman, J., Young, H.C., Mayo, J.W. Structure-function relationships in novel peptide dodecamers with broad-spectrum bactericidal and endotoxin-neutralizing activities. Biochem J 2000, 349: 717-28.
84. Ilyina, E., Roongta, V., Mayo, K.H. NMR structure of a de novo designed, peptide 33mer with two distinct, compact β-sheet folds. Biochemistry 1997, 36: 5245-50.
85. Blazyk, J., Wiegand, R., Klein, J. et al. A novel linear amphipathic β-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem 2001, 276: 27899-906.
86. Lai, J.R., Huck, B.R., Weisblum, B., Gellman, S.H. Design of non-cysteine-containing antimicrobial β-hairpins: Structure-activity relationship studies with linear protegrin-1 analogues. Biochemistry 2002, 41: 12835-42.
87. Muhle, S.A., Tam, J.P. Design of Gram-negative selective antimicrobial peptides. Biochemistry 2001, 40: 5777-85.
88. Boman, H.G., Wade, D., Boman, I.A., Wahlin, B., Merrifield, R.B. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett 1989, 259: 103-6.
89. Shin, S.Y., Kang, J.H., Lee, M.K., Kim, S.Y., Kim, Y., Hahm, K.S. Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect. Biochem Mol Biol Int 1998, 44: 1119-26.
90. Shin, S.Y., Lee, S.H., Yang, S.T. et al. Antibacterial, antitumor and hemolytic activities of α-helical antibiotic peptide, P18 and its analogs. J Pept Res 2001, 58: 504-14.
91. Tam, J.P., Lu, Y.A., Yang, J.L. Antimicrobial dendrimeric peptides. Eur J Biochem 2002, 269: 923-32.
92. Shafer, W.M., Pohl, J., Onunka, V.C., Bangalore, N., Travis, J. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem 1991, 266: 112-6.
93. Mak, P., Pohl, J., Dubin, A. et al. The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int J Antimicrob Agents 2003, 21: 13-9.
94. Wakabayashi, H., Matsumoto, H., Hashimoto, K., Teraguchi, S., Takase, M., Hayasawa, H. N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob Agents Chemother 1999, 43: 1267-9.
95. Majerle, A., Kidric, J., Jerala, R. Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J Antimicrob Chemother 2003, 51: 1159-65.
96. Avrahami, D., Shai, Y. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry 2002, 41: 2254-63.
97. Chicharro, C., Granata, C., Lozano, R., Andreu, D., Rivas, L. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob Agents Chemother 2001, 45: 2441-9.
98. Lockwood, N.A., Haseman, J., Tirrell, M.V., Mayo, K.H. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem J 2003, in press.
99. Savage, P.B., Li, C., Taotafa, U., Ding, B., Guan, Q. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett 2002, 217: 1-7.
100. Kikuchi, K., Bernard, E.M., Sadownik, A., Regen, S.L., Armstrong, D. Antimicrobial activities of squalamine mimics. Antimicrob Agents Chemother 1997, 41: 1433-8.
101. Porter, E.A., Weisblum, B., Gellman, S.H. Mimicry of host-defense peptides by unnatural oligomers: Antimicrobial β-peptides. J Am Chem Soc 2002, 124: 7324-7330.
102. Raguse, T.L., Porter, E.A., Weisblum, B., Gellman, S.H. Structure-activity studies of 14-helical antimicrobial β-peptides: Probing the relationship between conformational stability and antimicrobial potency. J Am Chem Soc 2002, 124: 12774-85.
103. Tew, G.N., Liu, D., Chen, B. et al. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci USA 2002, 99: 5110-4.
104. American Society of Pathologists. United States geographic bacteria susceptibility patterns. Am J Clin Pathol 1998, 109: 144-52.
105. Mayer, K., Opal, S., Medeiros, A. Mechanisms of antibiotic resistance. In: Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. G.L. Mandell, R.G. Douglas, and J.E. Bennett (Eds.). Churchill Livingstone: New York 1995, 212-25.
106. Cevikbas, A. Antibacterial activity in the skin secretion of the frog Rana ridibunda. Toxicon 1978, 16: 195-7.
107. Amiche, M., Seon, A.A., Pierre, T.N., Nicolas, P. The dermaseptin precursors: A protein family with a common preproregion and a variable C-terminal antimicrobial domain. FEBS Lett 1999, 456: 352-6.
108. Qu, Z., Steiner, H., Engstrom, A., Bennich, H., Boman, H.G. Insect immunity: Isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi. Eur J Biochem 1982, 127: 219-24.
109. Elsbach, P., Weiss, J. Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol 1998, 10: 45-9.
110. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1992, 1121: 130-6.
111. Steinberg, D.A., Hurst, M.A., Fujii, C.A. et al. Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 1997, 41: 1738-42.
112. Woolley, G.A., Wallace, B.A. Model ion channels: Gramicidin and alamethicin. J Membr Biol 1992, 129: 109-36.
113. Li, Z.Q., Merrifield, R.B., Boman, I.A., Boman, H.G. Effects on electrophoretic mobility and antibacterial spectrum of removal of two residues from synthetic sarcotoxin IA and addition of the same residues to cecropin B. FEBS Lett 1988, 231: 299-302.
114. Lauth, X., Nesin, A., Briand, J.P., Roussel, J.P., Hetru, C. Isolation, characterization and chemical synthesis of a new insect defensin from Chironomus plumosus (Diptera). Insect Biochem Mol Biol 1998, 28: 1059-66.
115. Subbalakshmi, C., Krishnakumari, V., Nagaraj, R., Sitaram, N. Requirements for antibacterial and hemolytic activities in the -bovine neutrophil derived 13-residue peptide indolicidin. FEBS Lett 1996, 395: 48-52.
116. Li, C., Lewis, M.R., Gilbert, A.B. et al. Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives. Antimicrob Agents Chemother 1999, 43: 1347-9.
117. Ding, B., Guan, Q., Walsh, J.P. et al. Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics. J Med Chem 2002, 45: 663-9.
118. Shai, Y., Oren, Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 2001, 22: 1629-41.
119. Tam, J.P., Lu, Y.A., Yang, J.L. Design of salt-insensitive glycine-rich antimicrobial peptides with cyclic tricystine structures. Biochemistry 2000, 39: 7159-69.
120. Park, Y., Lee, D.G., Jang, S.H. et al. A Leu-Lys-rich antimicrobial peptide: Activity and mechanism. Biochim Biophys Acta 2003, 1645: 172-82.
121. Ge, Y., MacDonald, D.L., Holroyd, K.J., Thornsberry, C., Wexler, H., Zasloff, M. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 1999, 43: 782-8.
122. Gesell, J., Zasloff, M., Opella, S.J. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an α-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J Biomol NMR 1997, 9: 127-35.
123. Fahrner, R.L., Dieckmann, T., Harwig, S.S., Lehrer, R.I., Eisenberg, D., Feigon, J. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol 1996, 3: 543-50.
124. Rozek, A., Friedrich, C.L., Hancock, R.E. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 2000, 39: 15765-74.
125. Humphrey, W., Dalke, A., Schulten, K. VMD - visual molecular dynamics. J Mol Graph 1996, 14: 33-8.